RLFTF
RELIEF THERAPEUTICS HLDG by RELIEF THERAPEUTICS HLDG AG (RLFTF)
$
04About RELIEF THERAPEUTICS HLDG by RELIEF THERAPEUTICS HLDG AG (RLFTF)
RELIEF THERAPEUTICS Holding SA is a commercial-stage biopharmaceutical company, which engages in the research, development, and commercialization of treatment for rare debilitating conditions. The firm offers Physiomimic and TEHCLO, drug delivery platform technologies and a targeted clinical development pipeline consisting of risk-mitigated assets to address rare metabolic disorders, rare skin diseases, and rare respiratory diseases. It operates through the following geographical segments: Switzerland, Europe, North America, and Rest of the World. The company was founded in 2013 and is headquartered in Geneva, Switzerland.
Details
Daily high
$3.04
Daily low
$2.83
Price at open
$2.99
52 Week High
$7.66
52 Week Low
$1.10
Market cap
38.1M
Dividend yield
0.00%
Volume
1,141
Avg. volume
2,108
P/E ratio
-1.95
RELIEF THERAPEUTICS HLDG by RELIEF THERAPEUTICS HLDG AG News
Details
Daily high
$3.04
Daily low
$2.83
Price at open
$2.99
52 Week High
$7.66
52 Week Low
$1.10
Market cap
38.1M
Dividend yield
0.00%
Volume
1,141
Avg. volume
2,108
P/E ratio
-1.95